This enabled a unique evaluation of the iodine avidity in primary tumour tissue, resected lymph node metastases, and comparison of avidity to the expression of iodine-transport related proteins (NIS, TPO, TSHR and pendrin), as well as mutations in the TERT promoter and codon V600 of the BRAF gene. The gene discussed is TPO; the disease is neoplasm.